Progyny, Inc. (PGNY) stock
PGNYNasdaqServices-Misc Health & Allied Services, NECFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 21/305% below fair value
$36.18−0.40 (-1.09%)
Close on Nov 13, 2026Market cap $2.78BP/E 33.2Yield –
Earnings
Progyny's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.
Next report
Feb 25, 2027
Q4 FY2026 · estimated, after the close
Revenue, Q3 FY2026
$341.30M
+8.9% on a year earlier
Adjusted Earnings per Diluted Share, Q3 FY2026
$0.52
$0.45 a year earlier
Latest guidance
Raised
Nov 4, 2026 · 8 items
Quarterly results
Revenue and earnings per share from each of Progyny's earnings releases, newest first
| Quarter | Reported | Revenue | YoY | EPS | Adj. EPS | Source |
|---|---|---|---|---|---|---|
| Q4 FY2026ended Dec 31, 2026 | Feb 25, 2027Expected | – | – | – | – | – |
| Q3 FY2026ended Sep 30, 2026 | Nov 4, 2026after the close | $341.30M | +8.9% | $0.32 | $0.52 | Release |
| Q2 FY2026ended Jun 30, 2026 | Aug 6, 2026after the close | $350.50M | – | – | – | Release |
| Q1 FY2026ended Mar 31, 2026 | May 7, 2026after the close | $328.50M | +1.4% | $0.29 | $0.50 | Release |
| Q4 FY2025ended Dec 31, 2025 | Feb 26, 2026after the close | $318.40M | +6.7% | $0.14 | $0.48 | Release |
| Q3 FY2025ended Sep 30, 2025 | Nov 6, 2025after the close | $313.35M | +9.3% | $0.15 | $0.45 | Release |
| Q2 FY2025ended Jun 30, 2025 | Jul 8, 2025before the open | – | – | – | – | Release |
| Q1 FY2025ended Mar 31, 2025 | May 8, 2025after the close | $324.00M | +16.5% | $0.17 | $0.48 | Release |
| Q4 FY2024ended Dec 31, 2024 | Feb 27, 2025after the close | $298.40M | +10.6% | $0.12 | $0.42 | Release |
| Q3 FY2024ended Sep 30, 2024 | Nov 12, 2024after the close | $286.60M | +2.0% | $0.11 | $0.40 | Release |
| Q2 FY2024ended Jun 30, 2024 | Aug 6, 2024after the close | $304.10M | +8.8% | $0.17 | $0.43 | Release |
| Q1 FY2024ended Mar 31, 2024 | May 9, 2024after the close | $278.10M | +7.6% | $0.17 | $0.39 | Release |
| Q4 FY2023ended Dec 31, 2023 | Feb 27, 2024after the close | $269.90M | +25.9% | $0.13 | $0.32 | Release |
| Q3 FY2023ended Sep 30, 2023 | Nov 7, 2023after the close | $280.90M | +36.8% | $0.16 | – | Release |
| Q2 FY2023ended Jun 30, 2023 | Aug 3, 2023after the close | $279.40M | +43.3% | $0.15 | – | Release |
| Q1 FY2023ended Mar 31, 2023 | May 8, 2023after the close | $258.40M | +50.1% | $0.18 | – | Release |
| Q4 FY2022ended Dec 31, 2022 | Feb 27, 2023after the close | $214.30M | +67.9% | $0.03 | – | Release |
| Q3 FY2022ended Sep 30, 2022 | Nov 3, 2022after the close | $205.40M | +67.9% | $0.13 | – | Release |
| Q2 FY2022ended Jun 30, 2022 | Aug 4, 2022after the close | $195.00M | – | $0.09 | – | Release |
| Q1 FY2022ended Mar 31, 2022 | May 5, 2022after the close | $172.20M | – | $0.05 | – | Release |
| Q4 FY2021ended Dec 31, 2021 | Feb 28, 2022after the close | $127.60M | – | $0.15 | – | Release |
| Q3 FY2021ended Sep 30, 2021 | Nov 4, 2021after the close | $122.30M | – | $0.17 | – | Release |
| Q2 FY2021ended Jun 30, 2021 | Aug 5, 2021after the close | – | – | – | – | Filing |
| Q1 FY2021ended Mar 31, 2021 | May 6, 2021after the close | – | – | – | – | Filing |
| Q4 FY2020ended Dec 31, 2020 | Feb 24, 2021after the close | – | – | – | – | Filing |
| Q3 FY2020ended Sep 30, 2020 | Nov 5, 2020after the close | – | – | – | – | Filing |
Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.
Current guidance
Progyny's latest outlook for periods it has not reported yet, compared with what it said before
| Metric | Period | Guidance | Before | Change | Given |
|---|---|---|---|---|---|
| RevenueGAAP | Q4 FY2026 | $344.70M – $364.70M | – | New | Nov 4, 2026 |
| Adjusted EBITDAnon-GAAP | Q4 FY2026 | $57.90M – $62.90M | – | New | Nov 4, 2026 |
| Net income per diluted shareGAAP | Q4 FY2026 | $0.36 – $0.41 | – | New | Nov 4, 2026 |
| Adjusted earnings per diluted sharenon-GAAP | Q4 FY2026 | $0.53 – $0.58 | – | New | Nov 4, 2026 |
| RevenueGAAP | FY2026 | $1.37B – $1.39B | $1.36B – $1.41B | Narrowed | Nov 4, 2026 |
| Revenue | FY2026 | $1.36B – $1.39B | $1.37B – $1.41B | Lowered | Aug 6, 2026 |
| Revenue growth | FY2026 | +5.9% – +9% | – | New | May 7, 2026 |
| Adjusted EBITDAnon-GAAP | FY2026 | $235.00M – $240.00M | $224.00M – $239.00M | Raised | Nov 4, 2026 |
| Adjusted EBITDAnon-GAAP | FY2026 | $233.00M – $240.00M | $232.00M – $244.00M | Narrowed | Aug 6, 2026 |
| Net income per diluted shareGAAP | FY2026 | $1.30 – $1.35 | $1.10 – $1.22 | Raised | Nov 4, 2026 |
| per diluted shareGAAP | FY2026 | $1.26 – $1.32 | $1.23 – $1.34 | Narrowed | Aug 6, 2026 |
| Adjusted earnings per diluted sharenon-GAAP | FY2026 | $2.09 – $2.13 | $1.83 – $1.95 | Raised | Nov 4, 2026 |
| Adjusted earnings per diluted sharenon-GAAP | FY2026 | $2.04 – $2.10 | $1.98 – $2.09 | Raised | Aug 6, 2026 |
| Net incomeGAAP | FY2026 | $95.40M – $106.10M | – | New | Feb 26, 2026 |
Guidance vs results
The last range Progyny gave before each report, against the figure it then reported. Full years add up the four quarters.
| Period | Metric | Guidance | Actual | Result |
|---|---|---|---|---|
| Q3 FY2026 | Adjusted earnings per diluted share | $0.50 – $0.52 | $0.52 | Within range |
| Q3 FY2026 | EPS (GAAP) | $0.30 – $0.33 | $0.32 | Within range |
| Q3 FY2026 | Revenue | $335.00M – $345.00M | $341.30M | Within range |
| Q2 FY2026 | Revenue | $342.00M – $355.00M | $350.50M | Within range |
| Q1 FY2026 | Adjusted earnings per diluted share | $0.42 – $0.45 | $0.50 | Above range |
| Q1 FY2026 | EPS (GAAP) | $0.24 – $0.27 | $0.29 | Above range |
| Q1 FY2026 | Revenue | $319.00M – $332.00M | $328.50M | Within range |
| Q4 FY2025 | Adjusted earnings per diluted share | $0.37 – $0.40 | $0.48 | Above range |
| Q4 FY2025 | EPS (GAAP) | $0.14 – $0.17 | $0.14 | Within range |
| Q4 FY2025 | Revenue | $292.70M – $307.70M | $318.40M | Above range |
| Q4 FY2025 | Revenue growth | -1.9% – +3.1% | +6.7% | Above range |
| Q1 FY2025 | Adjusted earnings per diluted share | $0.44 – $0.47 | $0.48 | Above range |
| Q1 FY2025 | EPS (GAAP) | $0.17 – $0.20 | $0.17 | Within range |
| Q1 FY2025 | Revenue | $300.00M – $318.00M | $324.00M | Above range |
| Q4 FY2024 | Adjusted earnings per diluted share | $0.31 – $0.35 | $0.42 | Above range |
| Q4 FY2024 | EPS (GAAP) | $0.07 – $0.10 | $0.12 | Above range |
| Q4 FY2024 | Revenue | $266.20M – $281.20M | $298.40M | Above range |
| Q4 FY2024 | Revenue growth | -1% – +4% | +10.56% | Above range |
| Q3 FY2024 | Adjusted earnings per diluted share | $0.35 – $0.38 | $0.40 | Above range |
| Q3 FY2024 | EPS (GAAP) | $0.11 – $0.14 | $0.11 | Within range |
| Q3 FY2024 | Revenue | $290.00M – $303.00M | $286.60M | Below range |
| Q2 FY2024 | Adjusted earnings per diluted share | $0.39 – $0.41 | $0.43 | Above range |
| Q2 FY2024 | EPS (GAAP) | $0.16 – $0.18 | $0.17 | Within range |
| Q2 FY2024 | Revenue | $300.00M – $310.00M | $304.10M | Within range |
| Q1 FY2024 | Adjusted earnings per diluted share | $0.33 – $0.35 | $0.39 | Above range |
| Q1 FY2024 | EPS (GAAP) | $0.12 – $0.13 | $0.17 | Above range |
| Q1 FY2024 | Revenue | $285.00M – $292.00M | $278.10M | Below range |
| Q4 FY2023 | EPS (GAAP) | $0.10 – $0.11 | $0.13 | Above range |
| Q4 FY2023 | Revenue | $268.30M – $276.30M | $269.90M | Within range |
| Q3 FY2023 | EPS (GAAP) | $0.09 – $0.10 | $0.16 | Above range |
| Q3 FY2023 | Revenue | $268.00M – $273.00M | $280.90M | Above range |
| Q2 FY2023 | EPS (GAAP) | $0.09 – $0.10 | $0.15 | Above range |
| Q2 FY2023 | Revenue | $260.00M – $265.00M | $279.40M | Above range |
| Q1 FY2023 | EPS (GAAP) | $0.07 – $0.08 | $0.18 | Above range |
| Q1 FY2023 | Revenue | $245.00M – $250.00M | $258.40M | Above range |
| Q4 FY2022 | EPS (GAAP) | -$0.01 – $0.02 | $0.03 | Above range |
| Q4 FY2022 | Revenue | $202.40M – $212.40M | $214.30M | Above range |
| Q3 FY2022 | EPS (GAAP) | $0.02 – $0.03 | $0.13 | Above range |
| Q3 FY2022 | Revenue | $190.00M – $197.00M | $205.40M | Above range |
| Q2 FY2022 | EPS (GAAP) | $0.01 – $0.02 | $0.09 | Above range |
| Q2 FY2022 | Revenue | $188.00M – $193.00M | $195.00M | Above range |
| Q1 FY2022 | EPS (GAAP) | -$0.02 – -$0.01 | $0.05 | Above range |
| Q1 FY2022 | Revenue | $165.00M – $170.00M | $172.20M | Above range |
| Q4 FY2021 | EPS (GAAP) | $0.01 – $0.03 | $0.15 | Above range |
| Q4 FY2021 | Revenue | $133.90M – $140.90M | $127.60M | Below range |
Guidance history
Every forecast Progyny put in an earnings release, newest first
| Given | Metric | Period | Guidance | Change |
|---|---|---|---|---|
| Nov 4, 2026 | Adjusted EBITDA | Q4 FY2026 | $57.90M – $62.90M | New |
| Nov 4, 2026 | Adjusted EBITDA | FY2026 | $235.00M – $240.00M | Raised |
| Nov 4, 2026 | Adjusted earnings per diluted share | Q4 FY2026 | $0.53 – $0.58 | New |
| Nov 4, 2026 | Adjusted earnings per diluted share | FY2026 | $2.09 – $2.13 | Raised |
| Nov 4, 2026 | Net income per diluted share | Q4 FY2026 | $0.36 – $0.41 | New |
| Nov 4, 2026 | Net income per diluted share | FY2026 | $1.30 – $1.35 | Raised |
| Nov 4, 2026 | Revenue | Q4 FY2026 | $344.70M – $364.70M | New |
| Nov 4, 2026 | Revenue | FY2026 | $1.37B – $1.39B | Narrowed |
| Aug 6, 2026 | Adjusted EBITDA | FY2026 | $233.00M – $240.00M | Narrowed |
| Aug 6, 2026 | Adjusted EBITDA | Q3 FY2026 | $56.00M – $59.00M | New |
| Aug 6, 2026 | Adjusted earnings per diluted share | FY2026 | $2.04 – $2.10 | Raised |
| Aug 6, 2026 | Adjusted earnings per diluted share | Q3 FY2026 | $0.50 – $0.52 | New |
| Aug 6, 2026 | per diluted share | FY2026 | $1.26 – $1.32 | Narrowed |
| Aug 6, 2026 | per diluted share | Q3 FY2026 | $0.30 – $0.33 | New |
| Aug 6, 2026 | Revenue | FY2026 | $1.36B – $1.39B | Lowered |
| Aug 6, 2026 | Revenue | Q3 FY2026 | $335.00M – $345.00M | New |
| May 7, 2026 | Adjusted EBITDA | FY2026 | $232.00M – $244.00M | New |
| May 7, 2026 | Adjusted EBITDA | Q2 FY2026 | $58.00M – $62.00M | New |
| May 7, 2026 | Adjusted earnings per diluted share | FY2026 | $1.98 – $2.09 | New |
| May 7, 2026 | Adjusted earnings per diluted share | Q2 FY2026 | $0.50 – $0.53 | New |
| May 7, 2026 | Net income per diluted share | FY2026 | $1.23 – $1.34 | New |
| May 7, 2026 | Net income per diluted share | Q2 FY2026 | $0.31 – $0.35 | New |
| May 7, 2026 | Revenue growth | FY2026 | +5.9% – +9% | New |
| May 7, 2026 | Revenue | FY2026 | $1.37B – $1.41B | New |
| May 7, 2026 | Revenue growth | Q2 FY2026 | +2.7% – +6.6% | New |
| May 7, 2026 | Revenue | Q2 FY2026 | $342.00M – $355.00M | New |
| Feb 26, 2026 | Adjusted EBITDA | Q1 FY2026 | $51.00M – $55.00M | New |
| Feb 26, 2026 | Adjusted EBITDA | FY2026 | $224.00M – $239.00M | New |
| Feb 26, 2026 | Adjusted earnings per diluted share | Q1 FY2026 | $0.42 – $0.45 | New |
| Feb 26, 2026 | Adjusted earnings per diluted share | FY2026 | $1.83 – $1.95 | New |
| Feb 26, 2026 | per diluted share | Q1 FY2026 | $0.24 – $0.27 | New |
| Feb 26, 2026 | per diluted share | FY2026 | $1.10 – $1.22 | New |
| Feb 26, 2026 | Net income | Q1 FY2026 | $20.80M – $23.70M | New |
| Feb 26, 2026 | Net income | FY2026 | $95.40M – $106.10M | New |
| Feb 26, 2026 | Revenue | Q1 FY2026 | $319.00M – $332.00M | New |
| Feb 26, 2026 | Revenue | FY2026 | $1.36B – $1.41B | New |
| Nov 6, 2025 | Adjusted EBITDA | FY2025 | $216.00M – $220.00M | New |
| Nov 6, 2025 | Adjusted EBITDA | Q4 FY2025 | $45.30M – $49.30M | New |
| Nov 6, 2025 | Adjusted earnings per diluted share | FY2025 | $1.79 – $1.82 | New |
| Nov 6, 2025 | Adjusted earnings per diluted share | Q4 FY2025 | $0.37 – $0.40 | New |
| Nov 6, 2025 | per diluted share | FY2025 | $0.65 – $0.68 | New |
| Nov 6, 2025 | per diluted share | Q4 FY2025 | $0.14 – $0.17 | New |
| Nov 6, 2025 | Net income | FY2025 | $58.50M – $61.50M | New |
| Nov 6, 2025 | Net income | Q4 FY2025 | $12.50M – $15.50M | New |
| Nov 6, 2025 | Revenue growth | FY2025 | +8.2% – +9.5% | New |
| Nov 6, 2025 | Revenue | FY2025 | $1.26B – $1.28B | New |
| Nov 6, 2025 | Revenue change | Q4 FY2025 | -1.9% – +3.1% | New |
| Nov 6, 2025 | Revenue | Q4 FY2025 | $292.70M – $307.70M | New |
| May 8, 2025 | Adjusted EBITDA | Q2 FY2025 | $49.00M – $53.00M | New |
| May 8, 2025 | Adjusted EBITDA | FY2025 | $190.00M – $203.00M | Raised |
| May 8, 2025 | Adjusted earnings per diluted share | Q2 FY2025 | $0.40 – $0.43 | New |
| May 8, 2025 | Adjusted earnings per diluted share | FY2025 | $1.54 – $1.64 | Raised |
| May 8, 2025 | per diluted share | Q2 FY2025 | $0.13 – $0.16 | New |
| May 8, 2025 | per diluted share | FY2025 | $0.46 – $0.56 | Lowered |
| May 8, 2025 | Revenue | Q2 FY2025 | $310.00M – $325.00M | New |
| May 8, 2025 | Revenue | FY2025 | $1.19B – $1.24B | New |
| Feb 27, 2025 | Adjusted EBITDA | Q1 FY2025 | $53.00M – $57.00M | New |
| Feb 27, 2025 | Adjusted EBITDA | FY2025 | $188.00M – $201.00M | New |
| Feb 27, 2025 | Adjusted earnings per diluted share | Q1 FY2025 | $0.44 – $0.47 | New |
| Feb 27, 2025 | Adjusted earnings per diluted share | FY2025 | $1.52 – $1.62 | New |
| Feb 27, 2025 | per diluted share | Q1 FY2025 | $0.17 – $0.20 | New |
| Feb 27, 2025 | per diluted share | FY2025 | $0.49 – $0.59 | New |
| Feb 27, 2025 | Net income | Q1 FY2025 | $15.00M – $17.80M | New |
| Feb 27, 2025 | Net income | FY2025 | $45.00M – $53.90M | New |
| Feb 27, 2025 | Revenue | Q1 FY2025 | $300.00M – $318.00M | New |
| Feb 27, 2025 | Revenue | FY2025 | $1.18B – $1.23B | New |
| Nov 12, 2024 | Adjusted EBITDA | Q4 FY2024 | $37.80M – $42.80M | New |
| Nov 12, 2024 | Adjusted EBITDA | FY2024 | $189.00M – $194.00M | Lowered |
| Nov 12, 2024 | Adjusted earnings per diluted share | Q4 FY2024 | $0.31 – $0.35 | New |
| Nov 12, 2024 | Adjusted earnings per diluted share | FY2024 | $1.54 – $1.57 | Narrowed |
| Nov 12, 2024 | per diluted share | Q4 FY2024 | $0.07 – $0.10 | New |
| Nov 12, 2024 | per diluted share | FY2024 | $0.52 – $0.56 | Lowered |
| Nov 12, 2024 | Revenue growth | Q4 FY2024 | -1% – +4% | New |
| Nov 12, 2024 | Revenue | Q4 FY2024 | $266.20M – $281.20M | New |
| Nov 12, 2024 | Revenue growth | FY2024 | +4% – +6% | New |
| Nov 12, 2024 | Revenue | FY2024 | $1.14B – $1.15B | New |
| Aug 6, 2024 | Adjusted EBITDA | Q3 FY2024 | $47.50M – $51.00M | New |
| Aug 6, 2024 | Adjusted EBITDA | FY2024 | $199.00M – $209.00M | Lowered |
| Aug 6, 2024 | Adjusted earnings per diluted share | Q3 FY2024 | $0.35 – $0.38 | New |
| Aug 6, 2024 | Adjusted earnings per diluted share | FY2024 | $1.53 – $1.61 | Lowered |
| Aug 6, 2024 | per diluted share | Q3 FY2024 | $0.11 – $0.14 | New |
| Aug 6, 2024 | per diluted share | FY2024 | $0.57 – $0.64 | Lowered |
| Aug 6, 2024 | Revenue | Q3 FY2024 | $290.00M – $303.00M | New |
| Aug 6, 2024 | Revenue | FY2024 | $1.17B – $1.20B | Lowered |
| May 9, 2024 | Adjusted EBITDA | Q2 FY2024 | $52.00M – $55.00M | New |
| May 9, 2024 | Adjusted EBITDA | FY2024 | $216.00M – $226.00M | Lowered |
| May 9, 2024 | Adjusted earnings per diluted share | Q2 FY2024 | $0.39 – $0.41 | New |
| May 9, 2024 | Adjusted earnings per diluted share | FY2024 | $1.61 – $1.68 | Raised |
| May 9, 2024 | per diluted share | Q2 FY2024 | $0.16 – $0.18 | New |
| May 9, 2024 | per diluted share | FY2024 | $0.68 – $0.75 | Raised |
| May 9, 2024 | Revenue | Q2 FY2024 | $300.00M – $310.00M | New |
| May 9, 2024 | Revenue | FY2024 | $1.23B – $1.27B | Lowered |
| Feb 27, 2024 | Adjusted EBITDA | Q1 FY2024 | $49.00M – $51.00M | New |
| Feb 27, 2024 | Adjusted EBITDA | FY2024 | $224.00M – $232.00M | New |
| Feb 27, 2024 | Adjusted earnings per diluted share | Q1 FY2024 | $0.33 – $0.35 | New |
| Feb 27, 2024 | Adjusted earnings per diluted share | FY2024 | $1.54 – $1.59 | New |
| Feb 27, 2024 | per diluted share | Q1 FY2024 | $0.12 – $0.13 | New |
| Feb 27, 2024 | per diluted share | FY2024 | $0.66 – $0.71 | New |
| Feb 27, 2024 | Revenue | Q1 FY2024 | $285.00M – $292.00M | New |
| Feb 27, 2024 | Revenue | FY2024 | $1.29B – $1.32B | New |
| Nov 7, 2023 | Adjusted EBITDA | Q4 FY2023 | $42.20M – $44.70M | New |
| Nov 7, 2023 | Adjusted EBITDA | FY2023 | $186.00M – $188.50M | Raised |
| Nov 7, 2023 | per diluted share | Q4 FY2023 | $0.10 – $0.11 | New |
| Nov 7, 2023 | per diluted share | FY2023 | $0.58 – $0.59 | Raised |
| Nov 7, 2023 | Revenue | Q4 FY2023 | $268.30M – $276.30M | New |
| Nov 7, 2023 | Revenue | FY2023 | $1.09B – $1.10B | Raised |
| Aug 3, 2023 | Adjusted EBITDA | Q3 FY2023 | $44.70M – $46.20M | New |
| Aug 3, 2023 | Adjusted EBITDA | FY2023 | $183.00M – $187.50M | Raised |
| Aug 3, 2023 | per diluted share | Q3 FY2023 | $0.09 – $0.10 | New |
| Aug 3, 2023 | per diluted share | FY2023 | $0.50 – $0.53 | Raised |
| Aug 3, 2023 | Revenue | Q3 FY2023 | $268.00M – $273.00M | New |
| Aug 3, 2023 | Revenue | FY2023 | $1.08B – $1.09B | Raised |
| May 8, 2023 | Adjusted EBITDA | Q2 FY2023 | $44.00M – $45.50M | New |
| May 8, 2023 | Adjusted EBITDA | FY2023 | $176.50M – $184.00M | Raised |
| May 8, 2023 | per diluted share | Q2 FY2023 | $0.09 – $0.10 | New |
| May 8, 2023 | per diluted share | FY2023 | $0.42 – $0.48 | Raised |
| May 8, 2023 | Revenue | Q2 FY2023 | $260.00M – $265.00M | New |
| May 8, 2023 | Revenue | FY2023 | $1.04B – $1.07B | Raised |
| Feb 27, 2023 | Adjusted EBITDA | Q1 FY2023 | $41.50M – $44.00M | New |
| Feb 27, 2023 | Adjusted EBITDA | FY2023 | $166.00M – $174.00M | New |
| Feb 27, 2023 | per diluted share | Q1 FY2023 | $0.07 – $0.08 | New |
| Feb 27, 2023 | per diluted share | FY2023 | $0.26 – $0.32 | New |
| Feb 27, 2023 | Revenue | Q1 FY2023 | $245.00M – $250.00M | New |
| Feb 27, 2023 | Revenue | FY2023 | $1.00B – $1.03B | New |
| Nov 3, 2022 | Adjusted EBITDA | Q4 FY2022 | $28.40M – $31.40M | New |
| Nov 3, 2022 | Adjusted EBITDA | FY2022 | $121.00M – $124.00M | Raised |
| Nov 3, 2022 | per diluted share | Q4 FY2022 | -$0.01 – $0.02 | New |
| Nov 3, 2022 | per diluted share | FY2022 | $0.26 – $0.29 | Raised |
| Nov 3, 2022 | Revenue | Q4 FY2022 | $202.40M – $212.40M | New |
| Nov 3, 2022 | Revenue | FY2022 | $775.00M – $785.00M | Raised |
| Aug 4, 2022 | Adjusted EBITDA | Q3 FY2022 | $29.60M – $31.60M | New |
| Aug 4, 2022 | Adjusted EBITDA | FY2022 | $114.00M – $122.00M | Raised |
| Aug 4, 2022 | per diluted share | Q3 FY2022 | $0.02 – $0.03 | New |
| Aug 4, 2022 | per diluted share | FY2022 | $0.14 – $0.19 | Raised |
| Aug 4, 2022 | Net income | Q3 FY2022 | $1.90M – $3.30M | New |
| Aug 4, 2022 | Net income | FY2022 | $13.80M – $19.50M | New |
| Aug 4, 2022 | Revenue | Q3 FY2022 | $190.00M – $197.00M | New |
| Aug 4, 2022 | Revenue | FY2022 | $750.00M – $775.00M | Raised |
| May 5, 2022 | Adjusted EBITDA | Q2 FY2022 | $28.00M – $30.00M | New |
| May 5, 2022 | Adjusted EBITDA | FY2022 | $111.00M – $122.00M | Raised |
| May 5, 2022 | per diluted share | Q2 FY2022 | $0.01 – $0.02 | New |
| May 5, 2022 | per diluted share | FY2022 | $0.07 – $0.14 | Raised |
| May 5, 2022 | Revenue | Q2 FY2022 | $188.00M – $193.00M | New |
| May 5, 2022 | Revenue | FY2022 | $735.00M – $775.00M | New |
| Feb 28, 2022 | Adjusted EBITDA | Q1 FY2022 | $23.50M – $24.50M | New |
| Feb 28, 2022 | Adjusted EBITDA | FY2022 | $110.00M – $122.00M | New |
| Feb 28, 2022 | per diluted share | Q1 FY2022 | -$0.02 – -$0.01 | New |
| Feb 28, 2022 | per diluted share | FY2022 | -$0.01 – $0.07 | New |
| Feb 28, 2022 | Revenue | Q1 FY2022 | $165.00M – $170.00M | New |
| Feb 28, 2022 | Revenue | FY2022 | $730.00M – $775.00M | New |
| Nov 4, 2021 | Adjusted EBITDA | Q4 FY2021 | $16.80M – $18.30M | New |
| Nov 4, 2021 | Adjusted EBITDA | FY2021 | $69.00M – $70.50M | New |
| Nov 4, 2021 | per diluted share | Q4 FY2021 | $0.01 – $0.03 | New |
| Nov 4, 2021 | per diluted share | FY2021 | $0.51 – $0.54 | New |
| Nov 4, 2021 | Revenue | Q4 FY2021 | $133.90M – $140.90M | New |
| Nov 4, 2021 | Revenue | FY2021 | $507.00M – $514.00M | New |
| Nov 4, 2021 | revenue | FY2022 | +50% | New |
Read from the company's earnings releases; each figure links to its sentence on hover. “Raised” and “Lowered” compare with the previous range for the same metric and period.
Press releases
Releases Progyny filed with the SEC as exhibits to Form 8-K or 6-K
- Results
- Results
- Results
- Results
- Results
- Results
- News
- Results
- Results
- Results
- Results
- Results
- Results
- Results
- Results
See a number that looks wrong?